Therapeutic Programs

therapeutic programs

Pipeline

Program Status of Development

Androgen Receptor

Castration-Resistant Prostate Cancer (Oral)

Exploratory Lead Optimization IND-Enabling Phase 1/2

Estrogen Receptor

Breast Cancer (Oral)

Exploratory Lead Optimization IND-Enabling Phase 1/2

Arvinas Target #1

(Undisclosed)

Exploratory Lead Optimization IND-Enabling Phase 1/2

Arvinas Target #2

(Undisclosed)

Exploratory Lead Optimization IND-Enabling Phase 1/2